Clinical trials
Recruiting Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Jinling Hospital, China | 3 |
| West China Hospital | 2 |
| AstraZeneca | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| China Medical University, China | 1 |
| DualityBio Inc. | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| Fudan University | 1 |
| Fujian Cancer Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 23 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Lung Neoplasms | 6 |
| Kidney Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Renal Cell | 3 |
| Gastrointestinal Neoplasms | 3 |
| Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Neuroendocrine | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.